General Information of Drug (ID: DM0QTUW)

Drug Name
DFV890
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [1]
Drug Type
Protein/peptide drug
Cross-matching ID
TTD ID
D05FGN

References

1 ClinicalTrials.gov (NCT04382053) Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia. U.S. National Institutes of Health.